Shares of Oryzon Genomics S.A. (trading on the Spanish Continuous Market under the ticker symbol ORY and over-the-counter as ORYZF) trade at approximately €2.85 per share. Equity valuations fluctuate continuously during active European trading hours based on daily market liquidity, clinical trial progress updates for its epigenetic therapies, and broader biotechnology sector sentiment.